These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 378311)

  • 21. [Effect of exogenous prostaglandins on the cardiovascular system].
    Alekseeva NP; Makoeva LD
    Sov Med; 1980; (2):96-101. PubMed ID: 6987749
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of gastric acid secretion and gastric erosions by prostacyclin and other prostaglandins.
    Whittle BJ
    Pol J Pharmacol Pharm; 1978; 30(2-3):167-70. PubMed ID: 353764
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of prostaglandins on gastric acid and mucus secretion.
    Metsä-Ketelä T; Parantainen J; Vapaatalo H
    Adv Prostaglandin Thromboxane Res; 1980; 8():1553-6. PubMed ID: 6990727
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of action of prostacyclin in human gastric mucosa.
    Simon B; Kather H
    Dig Dis Sci; 1979 Oct; 24(10):811-2. PubMed ID: 226339
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of the effect of prostaglandins E1, A1, B1 and F2-alpha on systemic and regional hemodynamics].
    Buniatian AA; Muratov VK; Flerov EV; Ismailov ShI
    Akush Ginekol (Mosk); 1979 Jan; (1):13-7. PubMed ID: 434342
    [No Abstract]   [Full Text] [Related]  

  • 26. Formation of prostacyclin and its product 6-oxo-PGF1alpha by the gastric mucosa of several species [proceedings].
    Moncada S; Salmon JA; Vane JR; Whittle BJ
    J Physiol; 1978 Feb; 275():4P-5P. PubMed ID: 344857
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mechanisms of the cytoprotective effect of prostaglandins].
    Maśliński S; Wojtecka-Lukasik E
    Acta Physiol Pol; 1983; 34 Suppl 25():53-77. PubMed ID: 6372371
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostacyclin-induced gastric mucosal vasodilation and inhibition of acid secretion in the dog.
    Waluś KM; Pawlik W; Konturek SJ
    Proc Soc Exp Biol Med; 1980 Feb; 163(2):228-32. PubMed ID: 6987676
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits.
    Armstrong JM; Lattimer N; Moncada S; Vane JR
    Br J Pharmacol; 1978 Jan; 62(1):125-30. PubMed ID: 339981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prostacyclin on gastric emptying and secretion in rhesus monkeys.
    Shea-Donohue PT; Myers L; Castell DO; Dubois A
    Adv Prostaglandin Thromboxane Res; 1980; 8():1557-8. PubMed ID: 6769318
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prostaglandins and the gastric mucosa barrier].
    Molinari F; Parodi MC
    Recenti Prog Med; 1982 Oct; 73(4):363-7. PubMed ID: 7156464
    [No Abstract]   [Full Text] [Related]  

  • 32. The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculature.
    Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):213-7. PubMed ID: 381947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syntheses and biological activities of some prostacyclin analogs.
    Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
    [No Abstract]   [Full Text] [Related]  

  • 34. [Do prostaglandins protect other cells besides those of the gastrointestinal epithelium?].
    Müller P; Dammann HG; Simon B
    Leber Magen Darm; 1982 Aug; 12(4):154-6. PubMed ID: 6752611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive effect of PGI2, 7-oxo-PGI2 and 17-aza-PGF2 alpha derivate on the development of indomethacin-induced intestinal mucosal damage in rats.
    Garamszegi M; Beró T; Jávor T; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):349-53. PubMed ID: 6397968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostacyclin and prostaglandin E2 selectively antagonize responses of human isolated myometrium to excitatory prostaglandins [proceedings].
    Bennett A; Sanger GJ
    J Physiol; 1979 Jul; 292():36P-37P. PubMed ID: 385831
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of the cytoprotective effect of prostacyclin on gastric epithelial cells of rats by colchicine.
    Karácsony G; Bálint GA; Lukács G; Varró V
    Acta Physiol Acad Sci Hung; 1982; 60(3):143-8. PubMed ID: 6764328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation and inhibition of cyclic AMP formation in isolated rat fat cell by prostacyclin (PGI2).
    Fredholm BB; Hjemdahl P; Hammarström S
    Biochem Pharmacol; 1980 Feb; 29(4):661-3. PubMed ID: 6245658
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilation produced by prostacyclin (PGI2) and 9(O)-thiaprostacyclin (PGI2-S) in the canine femoral circulation.
    Horii D; Kanayama T; Mori M; Shibasaki M; Ikegami S
    Eur J Pharmacol; 1978 Oct; 51(3):313-6. PubMed ID: 361420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.